Androlabs
Generated by Meeveem AI
"Men’s-health pharmaceuticals and education with an international reach"
About Androlabs
Androlabs is a London-headquartered pharmaceutical company dedicated to men’s health. Founded in February 2021, it commercialises Testavan, a testosterone replacement therapy for male hypogonadism, and Vitaros, an alprostadil cream for erectile dysfunction. Its medicines are supplied across international markets.
The company reports a team of 40 people across seven countries, working on medicines and initiatives to improve health awareness and access to care. An October 2026 reorganisation brought former Simple Pharma and Androlabs colleagues together as one Androlabs team, while Simple Pharma was divested to a separate owner. The business now focuses on expanding its men’s-health portfolio and partnerships.
Working across disciplines
Androlabs’ departments span operations, quality, regulatory affairs, data, marketing, commercial work, sales and finance. The company’s careers page encourages collaboration across teams and describes opportunities to take responsibility as the business develops.
Learning and development
The careers page states that every team member receives £300 each year for self-directed learning, with no approval required. Colleagues can also apply for support for larger development opportunities aligned with their career goals and the company’s work.
40
Team Members
2021
Founded
Pharma
Sector
Hybrid
Work Environment